 Phase 3, registrational studies remain on track for first half of 2023 topline data readout SCOTTSDALE, Ariz., Dec. 20, 2022 GLOBE NEWSWIRE Journey Medical Corporation NASDAQ: DERM Journey Medical, a commercial-stage biopharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions, today announced positive PK comparability data ... The post Journey Medical Corporation Announces Positive Comparative Phar... 